These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 23678073)

  • 81. Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation.
    Takwoingi Y; Whitworth H; Rees-Roberts M; Badhan A; Partlett C; Green N; Boakye A; Lambie H; Marongiu L; Jit M; White P; Deeks JJ; Kon OM; Lalvani A
    Health Technol Assess; 2019 May; 23(23):1-152. PubMed ID: 31138395
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Evaluation of human cytomegalovirus-specific CD8+ T-cells in allogeneic haematopoietic stem cell transplant recipients using pentamer and interferon-γ-enzyme-linked immunospot assays.
    Liu A; Ma Y; Wu W; Chen X; Huang Y; Hu J; Liang H; Wang H; Yang R; Fan J
    J Clin Virol; 2013 Oct; 58(2):427-31. PubMed ID: 23910932
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Impact of preformed T-cell alloreactivity by means of donor-specific and panel of reactive T cells (PRT) ELISPOT in kidney transplantation.
    Gandolfini I; Crespo E; Baweja M; Jarque M; Donadei C; Luque S; Montero N; Allesina A; Perin L; Maggiore U; Cravedi P; Bestard O
    PLoS One; 2018; 13(7):e0200696. PubMed ID: 30059561
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Analysis of the QuantiFERON-CMV assay, CMV viraemia and antiviral treatment following solid organ transplantation in Western Australia.
    Thompson G; Boan P; Baumwol J; Chakera A; MacQuillan G; Swaminathan S; Lavender M; Flexman J; James I; John M
    Pathology; 2018 Aug; 50(5):554-561. PubMed ID: 29945729
    [TBL] [Abstract][Full Text] [Related]  

  • 85. CMV-specific T-cell immunity in solid organ transplant recipients at low risk of CMV infection. Chronology and applicability in preemptive therapy.
    Mena-Romo JD; Pérez Romero P; Martín-Gandul C; Gentil MÁ; Suárez-Artacho G; Lage E; Sánchez M; Cordero E
    J Infect; 2017 Oct; 75(4):336-345. PubMed ID: 28599954
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Evaluation and significance of cytomegalovirus-specific cellular immune response in lung transplant recipients.
    Costa C; Astegiano S; Terlizzi ME; Sidoti F; Curtoni A; Solidoro P; Baldi S; Bergallo M; Cavallo R
    Transplant Proc; 2011 May; 43(4):1159-61. PubMed ID: 21620077
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Clinical utility of cytomegalovirus cell-mediated immunity in transplant recipients with cytomegalovirus viremia.
    Lisboa LF; Kumar D; Wilson LE; Humar A
    Transplantation; 2012 Jan; 93(2):195-200. PubMed ID: 22179399
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Role of cytomegalovirus specific cell-mediated immunity in the monitoring of cytomegalovirus infection among living donor liver transplantation adult recipients: A single-center experience.
    Bhugra A; Khodare A; Agarwal R; Pamecha V; Gupta E
    Transpl Infect Dis; 2023 Feb; 25(1):e14011. PubMed ID: 36602403
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Immunologic Monitoring after Allogeneic Stem Cell Transplantation: T-SPOT.CMV and QuantiFERON-CMV, Are They the Same?
    Callens R; Colman S; Delie A; Schauwvlieghe A; Lodewyck T; Selleslag D; Reynders M; Kerre T; Padalko E
    Transplant Cell Ther; 2023 Jun; 29(6):392.e1-392.e7. PubMed ID: 36963722
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Optimization of an elispot assay to detect cytomegalovirus-specific CD8+ T lymphocytes.
    Godard B; Gazagne A; Gey A; Baptiste M; Vingert B; Pegaz-Fiornet B; Strompf L; Fridman WH; Glotz D; Tartour E
    Hum Immunol; 2004 Nov; 65(11):1307-18. PubMed ID: 15556681
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Human microRNA sequencing and cytomegalovirus infection risk after kidney transplantation.
    Fernández-Ruiz M; López-García Á; Valverde-Manso A; Parra P; Rodríguez-Goncer I; Ruiz-Merlo T; López-Medrano F; González E; Polanco N; San Juan R; Andrés A; Aguado JM; Redondo N
    Am J Transplant; 2024 Jul; 24(7):1180-1192. PubMed ID: 38311311
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Dynamics of cell-mediated immune responses to cytomegalovirus in pediatric transplantation recipients.
    Patel M; Stefanidou M; Long CB; Fazzari MJ; Tesfa L; Del Rio M; Lamour J; Ricafort R; Madan RP; Herold BC
    Pediatr Transplant; 2012 Feb; 16(1):18-28. PubMed ID: 21762326
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Pretransplant immediately early-1-specific T cell responses provide protection for CMV infection after kidney transplantation.
    Bestard O; Lucia M; Crespo E; Van Liempt B; Palacio D; Melilli E; Torras J; Llaudó I; Cerezo G; Taco O; Gil-Vernet S; Grinyó JM; Cruzado JM
    Am J Transplant; 2013 Jul; 13(7):1793-805. PubMed ID: 23711167
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Living donor and recipient screening for latent tuberculosis infection by tuberculin skin test and interferon-gamma releasing assay in a country with an intermediate burden of tuberculosis.
    Moon SM; Park IA; Kim SM; Park SJ; Jung JH; Kim YH; Park JB; Hong B; Lee SO; Choi SH; Kim YS; Woo JH; Park SK; Lee SK; Park JS; Han DJ; Kim SH
    J Infect Chemother; 2013 Oct; 19(5):1009-13. PubMed ID: 23917533
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Pre-Transplant Frequencies of FoxP3
    Mooslechner AA; Schuller M; Pfeifer V; Klötzer KA; Prietl B; Kirsch AH; Stiegler P; Sucher R; Sourij H; Rosenkranz AR; Eller K
    Transpl Int; 2024; 37():12963. PubMed ID: 38868358
    [TBL] [Abstract][Full Text] [Related]  

  • 96. QuantiFERON-Cytomegalovirus Assay for Prediction of Cytomegalovirus Viremia in Kidney Transplant Recipients: Study From High Cytomegalovirus Seroprevalence Country.
    Pongsakornkullachart K; Chayakulkeeree M; Vongwiwatana A; Kantakamalakul W; Skulratanasak P; Phoompoung P
    Front Cell Infect Microbiol; 2022; 12():893232. PubMed ID: 35646728
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Heterologous Cytomegalovirus and Allo-Reactivity by Shared T Cell Receptor Repertoire in Kidney Transplantation.
    Stranavova L; Pelak O; Svaton M; Hruba P; Fronkova E; Slavcev A; Osickova K; Maluskova J; Hubacek P; Fronek J; Reinke P; Volk HD; Kalina T; Viklicky O
    Front Immunol; 2019; 10():2549. PubMed ID: 31736968
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON-CMV.
    Walker S; Fazou C; Crough T; Holdsworth R; Kiely P; Veale M; Bell S; Gailbraith A; McNeil K; Jones S; Khanna R
    Transpl Infect Dis; 2007 Jun; 9(2):165-70. PubMed ID: 17462006
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Comparative analysis of assays for detection of cell-mediated immunity toward cytomegalovirus and M. tuberculosis in samples from deceased organ donors.
    Schmidt T; Schub D; Wolf M; Dirks J; Ritter M; Leyking S; Singh M; Zawada AM; Blaes-Eise AB; Samuel U; Sester U; Sester M
    Am J Transplant; 2014 Sep; 14(9):2159-67. PubMed ID: 25040687
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
    Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
    Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.